IVINX | RNPHX | IVINX / RNPHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 39 years | 9 years | - |
Gain YTD | 2.697 | 2.083 | 129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 914M | 145B | 1% |
Annual Yield % from dividends | 0.55 | 1.00 | 55% |
Returns for 1 year | 16.39 | 15.55 | 105% |
Returns for 3 years | -36.62 | 2.67 | -1,371% |
Returns for 5 years | -25.83 | 32.49 | -80% |
Returns for 10 years | -10.02 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QQH | 67.39 | 0.79 | +1.19% |
HCM Defender 100 Index ETF | |||
DXJ | 107.70 | 1.24 | +1.16% |
WisdomTree Japan Hedged Equity ETF | |||
JOET | 39.36 | 0.33 | +0.84% |
Virtus Terranova US Quality Momentum ETF | |||
BBC | 21.83 | 0.01 | +0.04% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
JHCB | 21.00 | 0.01 | +0.02% |
JHancock Corporate Bond ETF |